Literature DB >> 9448622

Management of chylothorax.

N L Browse1, D R Allen, N M Wilson.   

Abstract

BACKGROUND: Chylothorax is a rare primary or secondary condition the optimum management of which remains uncertain.
METHODS: Twenty cases of chylothorax, including ten of primary chylothorax and ten secondary to either malignancy, subclavian vein thrombosis or lymphangioma treated between 1956 and 1986 have been reviewed.
RESULTS: Open pleurectomy was the most successful treatment in preventing reaccumulation of the effusion. Three patients had thoracic duct-azygous vein anastomoses, but all anastomoses were probably occluded within a year of surgery. Three patients have been lost to follow-up and five died within 2 years of their treatment, but 12 patients were alive and free from an effusion 3-22 years after treatment.
CONCLUSION: Patients with chylothorax should undergo lymphangiography to identify the cause and site of the lymphatic abnormality. Conservative treatment is successful in some patients but should be abandoned if the fluid loss exceeds 1.5 l/day for more than 5-7 days in an adult or more than 100 ml/day in a child. Parietal pleurectomy is the most successful treatment when no distinct chylous leak can be identified. Less commonly, an isolated chylous leak either in the chest or in the abdomen may be identified and this should be treated by direct ligation.

Entities:  

Mesh:

Year:  1997        PMID: 9448622

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  18 in total

Review 1.  Treatment of thoracic lymphangiomatosis.

Authors:  A Y Rostom
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

2.  Prediction of therapeutic effectiveness according to CT findings after therapeutic lymphangiography for lymphatic leakage.

Authors:  Rika Yoshimatsu; Takuji Yamagami; Hiroshi Miura; Tomohiro Matsumoto
Journal:  Jpn J Radiol       Date:  2013-10-26       Impact factor: 2.374

3.  Chylothorax after thoracoscopic esophagectomy.

Authors:  M Takemura; H Osugi; T Tokuhara; H Kinoshita; M Higashino
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-04

4.  Diffuse pulmonary lymphangiomatosis.

Authors:  Kunal C Kadakia; Sandeep M Patel; Eunhee S Yi; Andrew H Limper
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

5.  Postoperative chylothorax successfully treated using conservative strategies.

Authors:  Victoria Stager; Lam Le; Richard E Wood
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-04

6.  Chylothorax after pediatric cardiac surgery complicates short-term but not long-term outcomes-a propensity matched analysis.

Authors:  Nikoletta R Czobor; György Roth; Zsolt Prodán; Daniel J Lex; Erzsébet Sápi; László Ablonczy; Mihály Gergely; Edgar A Székely; János Gál; Andrea Székely
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

7.  Perioperative Considerations for Chylothorax.

Authors:  Joseph Morabito; Marshall T Bell; Leon J Montenij; Lena M Mayes; Zenggang Pan; Jan M Dieleman; Robert A Meguid; Karsten Bartels
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-06-03       Impact factor: 2.628

8.  Successful bilateral lung transplantation for lymphangiomatosis.

Authors:  C V Kinnier; J P C Eu; R D Davis; D N Howell; J Sheets; S M Palmer
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

Review 9.  Video assisted thoracoscopic and open chest surgery in diagnosis and treatment of malignant pleural diseases.

Authors:  Periklis Perikleous; David A Waller
Journal:  J Vis Surg       Date:  2017-06-22

10.  Delayed Chylothorax Following Blunt Chest Trauma.

Authors:  Mark Schurz; Nina Petras; Patrick Platzer; Friedrich Hofbauer; Vilmos Vécsei
Journal:  Eur J Trauma Emerg Surg       Date:  2009-03-16       Impact factor: 3.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.